Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;14(3):582-587.
doi: 10.1007/s13311-017-0554-7.

Genomics of Lithium Action and Response

Benjamin S Pickard  1
Affiliations
Review

Genomics of Lithium Action and Response

Benjamin S Pickard. Neurotherapeutics. 2017 Jul.

Abstract

Lithium is the most successful mood stabilizer treatment for bipolar disorder. However, unlike conventional drugs that are designed to interact with a specific molecular target, the actions of lithium are distributed across many biological processes and pathways. Treatment response is subject to genetic variation between individuals and similar genetic variation may dictate susceptibility to side effects. Transcriptomic, genomic, and cell-model research strategies have all been deployed in the search for the genetic factors and biological systems that mediate the interaction between genetics and the therapeutic actions of lithium. In this review, recent findings from genome-wide studies and patient cell lines will be summarized and discussed from a standpoint that genuine progress is being made to define clinically useful mechanisms of this treatment, to place it in the context of bipolar disorder pathology, and to move towards a time when the prescription of lithium is targeted to those individuals who will derive the greatest benefit.

Keywords: Bipolar disorder; Lithium; Pharmacogenomics; Therapeutic response; Toxicity.

PubMed Disclaimer

References

    1. Strobusch AD, Jefferson JW. The checkered history of lithium in medicine. Pharm Hist. 1980;22(2):72–76. - PubMed
    1. BALANCE investigators and collaborators. Geddes JR, Goodwin GM, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010;375(9712):385–395. doi: 10.1016/S0140-6736(09)61828-6. - DOI - PubMed
    1. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646. doi: 10.1136/bmj.f3646. - DOI - PubMed
    1. Shannon RD. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr A. 1976;32:751–767. doi: 10.1107/S0567739476001551. - DOI
    1. Briggs KT, Giulian GG, Li G, Kao JPY, Marino JP. A molecular model for lithium’s bioactive form. Biophys J. 2016;111(2):294–300. doi: 10.1016/j.bpj.2016.06.015. - DOI - PMC - PubMed

MeSH terms